(VIANEWS) – Shares of EUROAPI (CAC 40: EAPI.PA) fell by a staggering 21.81% to €12.51 at 10:54 EST on Wednesday, after four consecutive sessions in a row of gains. CAC 40 is falling 0.15% to €7,328.06, following the last session’s downward trend. This seems, at the moment, a somewhat down trend exchanging session today.
About EUROAPI
Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; prostaglandins; steroids & hormones; and Opiates and controlled substances. The company was incorporated in 2021 and is headquartered in Paris, France.
More news about EUROAPI (EAPI.PA).
